Literature DB >> 28903619

The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy.

Christopher Freese, Mickaela Sudhoff1, Luke Lewis, Michael Lamba, Jordan Kharofa.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28903619     DOI: 10.1080/0284186X.2017.1377847

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  1 in total

1.  18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation.

Authors:  John M David; Yong Yue; Kevin Blas; Andrew Hendifar; Peyman Kabolizadeh; Richard Tuli
Journal:  Adv Radiat Oncol       Date:  2019-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.